CompletedNot Applicable

Hemostatic Variables In Snakebite Study

India96 participantsStarted 2022-03-15

Plain-language summary

Background Novelty The global assays of coagulation, namely the viscoelastometric tests and clot waveform has never been studied in detail before in snakebite victims. The pathophysiology of VICC including specific factor deficiencies and serial trend in blood cell indices amongst various hematotoxic snakebite in the region is not known. No Indian study to date has systematically examined the changes in early laboratory tests results in envenomed and non envenomed snakebite victims.

Who can participate

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. All patients with history suggestive of snakebite presenting within 6 hours of snakebite AND
. All providing a written informed consent and/or assent

Exclusion criteria

. All patients of stings or bites other than snakes
. All patients who received antivenom or blood products at another institute
. All patients with known hematological malignancies, coagulation disorders, chronic liver or renal failure.
. All patients known to be on warfarin, heparin or any newer oral or injectable anticoagulants
. All withdrawing a consent later on, or withdrawing assent later on-

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

To study the serial change in CT of snakebite victims

Timeframe: up to 30 days

To study the serial change in fibrinogen levels of snakebite victims

Timeframe: up to 30 days

To study the serial change in D dimer levels of snakebite victims

Timeframe: up to 30 days

Trial details

NCT IDNCT04520282

SponsorJubilee Mission Medical College and Research Institute

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2023-07-31

View on ClinicalTrials.gov More Snake Bites trials

Plain-language summary

Who can participate

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria

. All patients with history suggestive of snakebite presenting within 6 hours of snakebite AND
. All providing a written informed consent and/or assent

Exclusion criteria

. All patients of stings or bites other than snakes
. All patients who received antivenom or blood products at another institute
. All patients with known hematological malignancies, coagulation disorders, chronic liver or renal failure.
. All patients known to be on warfarin, heparin or any newer oral or injectable anticoagulants
. All withdrawing a consent later on, or withdrawing assent later on-